We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+5.75%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$62.2B
AUM Growth
+$5.88B
Cap. Flow
+$2.89B
Cap. Flow %
4.64%
Top 10 Hldgs %
50.57%
Holding
2,272
New
161
Increased
855
Reduced
884
Closed
199

Sector Composition

Rank Sector Weight
1 Technology 4.57%
2 Financials 2.87%
3 Consumer Discretionary 1.79%
4 Communication Services 1.48%
5 Healthcare 1.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSM icon
1951
Fortuna Silver Mines
FSM
$2.59B
$102K ﹤0.01%
26,100
+8,694
+50% +$35.8K
KEEL
1952
Keel Infrastructure Corp
KEEL
$2.57B
$100K ﹤0.01%
19,880
-1,212
-6% -$7.48K
HL icon
1953
Hecla Mining
HL
$10.2B
$98K ﹤0.01%
18,819
+40
+0.2% +$224
INSG icon
1954
Inseego
INSG
$108M
$98K ﹤0.01%
1,683
-496
-23% -$32.2K
ADAM
1955
Adamas Trust
ADAM
$777M
$98K ﹤0.01%
6,570
+35
+0.5% +$573
PSO icon
1956
Pearson
PSO
$9.78B
$98K ﹤0.01%
11,678
+1,152
+11% +$9.89K
BTG icon
1957
B2Gold
BTG
$5.16B
$96K ﹤0.01%
24,428
+1,400
+6% +$5.62K
JQC icon
1958
Nuveen Credit Strategies Income Fund
JQC
$702M
$95K ﹤0.01%
14,711
-5,600
-28% -$36.4K
CTSO icon
1959
Cytosorbents Corp
CTSO
$22.6M
$93K ﹤0.01%
22,295
+200
+0.9% +$1.12K
VVR icon
1960
Invesco Senior Income Trust
VVR
$456M
$93K ﹤0.01%
21,400
AVDL
1961
DELISTED
Avadel Pharmaceuticals
AVDL
$92K ﹤0.01%
+11,351
New +$104K
ONCT
1962
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$90K ﹤0.01%
1,972
-230
-10% -$15.5K
RVSB icon
1963
Riverview Bancorp
RVSB
$107M
$88K ﹤0.01%
11,498
+1
+0% +$8
EXK
1964
Endeavour Silver
EXK
$2.32B
$87K ﹤0.01%
20,521
-5,725
-22% -$26.9K
KPTI icon
1965
Karyopharm Therapeutics
KPTI
$168M
$84K ﹤0.01%
873
-200
-19% -$19.9K
DFTX
1966
Definium Therapeutics
DFTX
$5.73B
$80K ﹤0.01%
3,872
-1,210
-24% -$38.6K
CX icon
1967
Cemex
CX
$17.4B
$79K ﹤0.01%
11,578
-4,500
-28% -$29.3K
HMY icon
1968
Harmony Gold Mining
HMY
$9.92B
$76K ﹤0.01%
18,404
-4,000
-18% -$15.3K
IAF
1969
abrdn Australia Equity Fund
IAF
$120M
$75K ﹤0.01%
4,136
GROY icon
1970
Gold Royalty Corp
GROY
$593M
$74K ﹤0.01%
+15,023
New +$75.8K
ORC
1971
Orchid Island Capital
ORC
$1.31B
$74K ﹤0.01%
+3,272
New +$78.4K
HBM icon
1972
Hudbay
HBM
$9.92B
$73K ﹤0.01%
10,000
SSKN
1973
DELISTED
Strata Skin Sciences
SSKN
$73K ﹤0.01%
5,001
UEC icon
1974
Uranium Energy
UEC
$4.71B
$73K ﹤0.01%
+21,787
New +$83.9K
INO icon
1975
Inovio Pharmaceuticals
INO
$79.8M
$72K ﹤0.01%
1,200
-109
-8% -$8.73K

Similar funds

Creative Planning's Q4 2021 Portfolio in Review

As of Q4 2021, Creative Planning held 2,272 positions worth $62.2B, up 10% from $56.4B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Creative Planning deployed $2.89B of net new capital in Q4 2021, opening 161 new positions and adding to 855 existing holdings. Its largest new stake was TELUS International: 731,047 shares worth $24.2M.

By sector, the portfolio is most concentrated in Technology at 4.6% of assets, up from 4.3% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Total Stock Market ETF, an estimated $78.3M trimmed.

  • Creative Planning's largest Q4 2021 buy was TELUS International: 731,047 shares worth $24.2M.
  • Creative Planning added most to Vanguard Total Bond Market in Q4 2021, an estimated $440M increase.
  • Creative Planning's biggest Q4 2021 reduction was Vanguard Total Stock Market ETF, cutting an estimated $78.3M.
  • Creative Planning fully exited Credit Suisse FI Large Cap Growth Enhanced Exchange Traded Notes in Q4 2021, selling an estimated $5.03M.
  • Creative Planning's ten largest holdings make up 51% of its $62.2B portfolio in Q4 2021.
  • Creative Planning opened 161 new positions and closed 199 in Q4 2021.
  • Creative Planning's portfolio value rose 10% quarter-over-quarter to $62.2B.

Based on Creative Planning's 13F filing for Q4 2021, filed 11 Feb 2022.